{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:10:15Z","timestamp":1791407415672,"version":"4.3.3"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1378\/chest.11-0793","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T06:46:17Z","timestamp":1325573177000},"page":"210-221","source":"Crossref","is-referenced-by-count":384,"title":["Inflammation in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"141","author":[{"given":"Laura C.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. John","family":"Wort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dorfm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Cohen-Kaminsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1378\/chest.11-0793_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.200510-112JH","article-title":"Pulmonary arterial hypertension","volume":"3","author":"Rubin","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"suppl 1","key":"10.1378\/chest.11-0793_bib2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1378\/chest.11-0793_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"Lane","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"10.1378\/chest.11-0793_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/humu.20285","article-title":"Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension","volume":"27","author":"Machado","year":"2006","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1378\/chest.11-0793_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thomson","year":"2000","journal-title":"J Med Genet"},{"issue":"2","key":"10.1378\/chest.11-0793_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"issue":"6917","key":"10.1378\/chest.11-0793_bib7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1378\/chest.11-0793_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00395-005-0511-6","article-title":"Inflammatory mediators in atherosclerotic vascular disease","volume":"100","author":"Zernecke","year":"2005","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"10.1378\/chest.11-0793_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1194\/jlr.R500004-JLR200","article-title":"Thematic review series: the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease","volume":"46","author":"Raines","year":"2005","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1378\/chest.11-0793_bib10","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/ATVBAHA.107.161224","article-title":"Chemokines in vascular dysfunction and remodeling","volume":"28","author":"Schober","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1378\/chest.11-0793_bib11","doi-asserted-by":"crossref","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","article-title":"Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure","volume":"297","author":"Stenmark","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1378\/chest.11-0793_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.106.655837","article-title":"Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation","volume":"115","author":"Sahara","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.11-0793_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.00094706","article-title":"Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1378\/chest.11-0793_bib14","doi-asserted-by":"crossref","first-page":"L360","DOI":"10.1152\/ajplung.00158.2002","article-title":"Decreased alveolar oxygen induces lung inflammation","volume":"284","author":"Madjdpour","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib15","doi-asserted-by":"crossref","first-page":"L238","DOI":"10.1152\/ajplung.90591.2008","article-title":"Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment","volume":"297","author":"Burke","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","article-title":"Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte\/macrophage lineage","volume":"168","author":"Frid","year":"2006","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1378\/chest.11-0793_bib17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.107.736801","article-title":"Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension","volume":"118","author":"Hong","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1378\/chest.11-0793_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00105807","article-title":"Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion","volume":"31","author":"Hamidi","year":"2008","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1378\/chest.11-0793_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200601-005OC","article-title":"HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques","volume":"174","author":"Marecki","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.11-0793_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1164\/rccm.200903-0355OC","article-title":"Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis","volume":"181","author":"Crosby","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1378\/chest.11-0793_bib21","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1164\/rccm.200608-1189OC","article-title":"Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling","volume":"175","author":"Taraseviciene-Stewart","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.11-0793_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0046-8177(97)90032-0","article-title":"Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection","volume":"28","author":"Cool","year":"1997","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib23","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1378\/chest.11-0793_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/thx.2008.106435","article-title":"Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children","volume":"64","author":"Hall","year":"2009","journal-title":"Thorax"},{"issue":"5","key":"10.1378\/chest.11-0793_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.carpath.2004.06.003","article-title":"Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts","volume":"13","author":"Pinto","year":"2004","journal-title":"Cardiovasc Pathol"},{"issue":"4 Part 1","key":"10.1378\/chest.11-0793_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.CIR.18.4.533","article-title":"The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects","volume":"18","author":"Heath","year":"1958","journal-title":"Circulation"},{"key":"10.1378\/chest.11-0793_bib27","unstructured":"Perros F, Dorfm\u00fcller P, Montani D, et al. Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Resp Crit Care Med, In press"},{"issue":"12","key":"10.1378\/chest.11-0793_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/jcp.44.12.1003","article-title":"Lung mast cells in plexogenic pulmonary arteriopathy","volume":"44","author":"Heath","year":"1991","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1378\/chest.11-0793_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thx.54.1.88","article-title":"Mast cell chymase in pulmonary hypertension","volume":"54","author":"Mitani","year":"1999","journal-title":"Thorax"},{"issue":"4","key":"10.1378\/chest.11-0793_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1164\/ajrccm.160.4.9810058","article-title":"Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease","volume":"160","author":"Hamada","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.11-0793_bib31","first-page":"A4289","article-title":"Circulating dendritic cells in idiopathic pulmonary arterial Hypertension and cirrhotic portopulmonary hypertension","volume":"179","author":"Le Pavec","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.11-0793_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.201006-0905OC","article-title":"C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension","volume":"184","author":"Montani","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.11-0793_bib33","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1378\/chest.11-0793_bib34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1378\/chest.11-0793_bib35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.11-0793_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/ajrccm.165.4.2012112","article-title":"Chemokine RANTES in severe pulmonary arterial hypertension","volume":"165","author":"Dorfm\u00fcller","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1378\/chest.11-0793_bib37","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.2106007","article-title":"CX(3)C chemokine fractalkine in pulmonary arterial hypertension","volume":"165","author":"Balabanian","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"10.1378\/chest.11-0793_bib38","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1161\/CIRCULATIONAHA.108.769646","article-title":"Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension","volume":"117","author":"Diller","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1378\/chest.11-0793_bib39","first-page":"705","article-title":"1999. Increase of cytokine production by pulmonary artery endothelial cells induced by supernatants from monocytes stimulated with autoantibodies against U1-ribonucleoprotein","volume":"17","author":"Okawa-Takatsuji","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1378\/chest.11-0793_bib40","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","article-title":"Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients","volume":"11","author":"Humbert","year":"1998","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1378\/chest.11-0793_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A hemodynamic study of pulmonary hypertension in sickle cell disease","volume":"365","author":"Parent","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1378\/chest.11-0793_bib42","doi-asserted-by":"crossref","first-page":"e7956","DOI":"10.1371\/journal.pone.0007956","article-title":"Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease","volume":"4","author":"Niu","year":"2009","journal-title":"PLoS ONE"},{"issue":"3 pt 1","key":"10.1378\/chest.11-0793_bib43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1164\/ajrccm.157.3.9707095","article-title":"Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines","volume":"157","author":"Lesprit","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1378\/chest.11-0793_bib44","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1378\/chest.11-0793_bib45","first-page":"414","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"17","author":"Asherson","year":"1990","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1378\/chest.11-0793_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/pcad.2002.129975","article-title":"Pulmonary hypertension associated with connective tissue disease","volume":"45","author":"Fagan","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1378\/chest.11-0793_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2796.1997.00191.x","article-title":"Hyperthyroidism and pulmonary hypertension","volume":"242","author":"Thurnheer","year":"1997","journal-title":"J Intern Med"},{"issue":"5","key":"10.1378\/chest.11-0793_bib48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.05.00133904","article-title":"Reversibility of pulmonary arterial hypertension in HIV\/HHV8-associated Castleman's disease","volume":"26","author":"Montani","year":"2005","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1378\/chest.11-0793_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"issue":"8","key":"10.1378\/chest.11-0793_bib50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.55.8.561","article-title":"Improvement of severe pulmonary hypertension in a patient with SLE","volume":"55","author":"Karmochkine","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1378\/chest.11-0793_bib51","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"Tanaka","year":"2002","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1378\/chest.11-0793_bib53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.11-0793_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.rmed.2006.04.026","article-title":"POEMS syndrome-related pulmonary hypertension is steroid-responsive","volume":"101","author":"Jouve","year":"2007","journal-title":"Respir Med"},{"issue":"8","key":"10.1378\/chest.11-0793_bib55","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/383037","article-title":"Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy","volume":"38","author":"Zuber","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1378\/chest.11-0793_bib56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1183\/09031936.00014209","article-title":"Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy","volume":"34","author":"Barnier","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1378\/chest.11-0793_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era","volume":"24","author":"Degano","year":"2010","journal-title":"AIDS"},{"issue":"1","key":"10.1378\/chest.11-0793_bib58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.11-0793_bib59","doi-asserted-by":"crossref","first-page":"H677","DOI":"10.1152\/ajpheart.91519.2007","article-title":"Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice","volume":"295","author":"Song","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1378\/chest.11-0793_bib60","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.11-0793_bib61","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-related pulmonary hypertension: analytic review of 131 cases","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"issue":"suppl 3","key":"10.1378\/chest.11-0793_bib62","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.aids.0000327515.55041.da","article-title":"Mediators involved in HIV-related pulmonary arterial hypertension","volume":"22","author":"Humbert","year":"2008","journal-title":"AIDS"},{"issue":"12","key":"10.1378\/chest.11-0793_bib63","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood.V93.12.4232","article-title":"Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy","volume":"93","author":"Ascherl","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1378\/chest.11-0793_bib64","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1189\/jlb.0405194","article-title":"HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells","volume":"79","author":"Caldwell","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1378\/chest.11-0793_bib65","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm\/145.5.1196","article-title":"Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy","volume":"145","author":"Mette","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1378\/chest.11-0793_bib66","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2005.05.198","article-title":"Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins","volume":"333","author":"Kanmogne","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"suppl 3","key":"10.1378\/chest.11-0793_bib67","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/01.aids.0000327516.55041.01","article-title":"From viral infection to pulmonary arterial hypertension: a role for viral proteins?","volume":"22","author":"Voelkel","year":"2008","journal-title":"AIDS"},{"issue":"12","key":"10.1378\/chest.11-0793_bib68","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa035115","article-title":"Expression of human herpesvirus 8 in primary pulmonary hypertension","volume":"349","author":"Cool","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1378\/chest.11-0793_bib69","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1165\/rcmb.2007-0368OC","article-title":"Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells","volume":"39","author":"Bull","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"48","key":"10.1378\/chest.11-0793_bib70","doi-asserted-by":"crossref","first-page":"37641","DOI":"10.1074\/jbc.M110.132415","article-title":"Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II","volume":"285","author":"Durrington","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1378\/chest.11-0793_bib71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2169\/internalmedicine.50.4143","article-title":"Pulmonary arterial hypertension associated with chronic active Epstein-Barr virus infection","volume":"50","author":"Hashimoto","year":"2011","journal-title":"Intern Med"},{"issue":"6","key":"10.1378\/chest.11-0793_bib72","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1378\/chest.10-1200","article-title":"Human \u03b3-herpesviruses Epstein-Barr virus and human herpesvirus-8 are not detected in the lungs of patients with severe pulmonary arterial hypertension","volume":"139","author":"Valmary","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.11-0793_bib73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000097495","article-title":"Absence of human herpesvirus 8 DNA sequences in lung biopsies from Israeli patients with pulmonary arterial hypertension","volume":"75","author":"Bendayan","year":"2008","journal-title":"Respiration"},{"issue":"12","key":"10.1378\/chest.11-0793_bib74","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.200504-546OC","article-title":"Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension","volume":"172","author":"Henke-Gendo","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 6","key":"10.1378\/chest.11-0793_bib75","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1378\/chest.10-0048","article-title":"Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective","volume":"137","author":"Graham","year":"2010","journal-title":"Chest"},{"issue":"11","key":"10.1378\/chest.11-0793_bib76","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.108.803221","article-title":"Cardiopulmonary manifestations of hepatosplenic schistosomiasis","volume":"119","author":"Lapa","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.11-0793_bib77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1055\/s-0029-1233307","article-title":"Pathology of pulmonary arterial hypertension","volume":"30","author":"Tuder","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.11-0793_bib78","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2353\/ajpath.2010.100063","article-title":"Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling","volume":"177","author":"Graham","year":"2010","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/oxfordjournals.epirev.a000804","article-title":"Toxic oil syndrome: the perspective after 20 years","volume":"23","author":"Posada de la Paz","year":"2001","journal-title":"Epidemiol Rev"},{"issue":"2","key":"10.1378\/chest.11-0793_bib80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1378\/chest.95.2.325","article-title":"Pulmonary hypertension due to toxic oil syndrome. A clinicopathologic study","volume":"95","author":"G\u00f3mez-S\u00e1nchez","year":"1989","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.11-0793_bib81","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1378\/chest.97.5.1032","article-title":"Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features","volume":"97","author":"Tazelaar","year":"1990","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.11-0793_bib82","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.00104706","article-title":"Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1378\/chest.11-0793_bib83","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1164\/rccm.200312-1686OC","article-title":"Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension","volume":"170","author":"Bull","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"10.1378\/chest.11-0793_bib84","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jacc.2008.12.038","article-title":"C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension","volume":"53","author":"Quarck","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1378\/chest.11-0793_bib85","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib86","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.20071008","article-title":"Pulmonary arterial remodeling induced by a Th2 immune response","volume":"205","author":"Daley","year":"2008","journal-title":"J Exp Med"},{"issue":"3","key":"10.1378\/chest.11-0793_bib87","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000111548","article-title":"Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension","volume":"75","author":"Ulrich","year":"2008","journal-title":"Respiration"},{"issue":"6","key":"10.1378\/chest.11-0793_bib88","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(86)80301-1","article-title":"Antinuclear antibodies in primary pulmonary hypertension","volume":"8","author":"Rich","year":"1986","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1378\/chest.11-0793_bib89","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","article-title":"Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension","volume":"60","author":"Tamby","year":"2005","journal-title":"Thorax"},{"issue":"4","key":"10.1378\/chest.11-0793_bib90","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","article-title":"Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension","volume":"28","author":"Tamby","year":"2006","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1378\/chest.11-0793_bib91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","article-title":"IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines","volume":"97","author":"Carvalho","year":"1996","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1378\/chest.11-0793_bib92","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1172\/JCI2261","article-title":"The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis","volume":"101","author":"Bordron","year":"1998","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1378\/chest.11-0793_bib93","first-page":"1481","article-title":"HLA markers for susceptibility and expression in scleroderma","volume":"32","author":"Gladman","year":"2005","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1378\/chest.11-0793_bib94","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2613.2006.00493.x","article-title":"Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats","volume":"87","author":"Vajner","year":"2006","journal-title":"Int J Exp Pathol"},{"issue":"11","key":"10.1378\/chest.11-0793_bib95","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","article-title":"New developments in mast cell biology","volume":"9","author":"Kalesnikoff","year":"2008","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1378\/chest.11-0793_bib96","doi-asserted-by":"crossref","first-page":"L668","DOI":"10.1152\/ajplung.00108.2003","article-title":"Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells","volume":"286","author":"Davie","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1378\/chest.11-0793_bib97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","article-title":"Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension","volume":"178","author":"Perros","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 1","key":"10.1378\/chest.11-0793_bib98","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib99","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","article-title":"Interleukin-6 overexpression induces pulmonary hypertension","volume":"104","author":"Steiner","year":"2009","journal-title":"Circ Res"},{"issue":"2","key":"10.1378\/chest.11-0793_bib100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/aps.2010.187","article-title":"Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats","volume":"32","author":"Li","year":"2011","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1378\/chest.11-0793_bib101","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1357-2725(96)00159-8","article-title":"Nuclear factor-kappa B","volume":"29","author":"Barnes","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1378\/chest.11-0793_bib102","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1165\/ajrcmb.21.3.3611","article-title":"Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages","volume":"21","author":"Raychaudhuri","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1378\/chest.11-0793_bib103","doi-asserted-by":"crossref","first-page":"L1473","DOI":"10.1152\/ajplung.00197.2006","article-title":"Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle","volume":"292","author":"Hagen","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"10.1378\/chest.11-0793_bib104","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.109.197491","article-title":"Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17\/92 pathway","volume":"104","author":"Brock","year":"2009","journal-title":"Circ Res"},{"issue":"4","key":"10.1378\/chest.11-0793_bib105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1183\/09031936.00028310","article-title":"Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats","volume":"37","author":"Price","year":"2011","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1378\/chest.11-0793_bib106","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/rccm.200909-1367OC","article-title":"Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension","volume":"182","author":"Hecker","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"2 pt 1","key":"10.1378\/chest.11-0793_bib107","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-6749(00)90084-8","article-title":"Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells","volume":"105","author":"Molet","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1378\/chest.11-0793_bib108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00408-010-9232-9","article-title":"CXC-chemokine ligand 10 in idiopathic pulmonary arterial hypertension: marker of improved survival","volume":"188","author":"Heresi","year":"2010","journal-title":"Lung"},{"issue":"6","key":"10.1378\/chest.11-0793_bib109","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1165\/ajrcmb.11.6.7946395","article-title":"Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline","volume":"11","author":"Voelkel","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1378\/chest.11-0793_bib110","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","article-title":"Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations","volume":"11","author":"Gourh","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1378\/chest.11-0793_bib111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1513\/pats.200603-038MS","article-title":"Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease","volume":"3","author":"Eddahibi","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"10.1378\/chest.11-0793_bib112","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000237166","article-title":"Pulmonary hypertension in rats. 2. Role of interleukin-6","volume":"108","author":"Miyata","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1378\/chest.11-0793_bib113","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-10-6","article-title":"Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice","volume":"10","author":"Savale","year":"2009","journal-title":"Respir Res"},{"issue":"1","key":"10.1378\/chest.11-0793_bib114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5551\/jat.11.15","article-title":"Regulation of CX3CL1\/fractalkine expression in endothelial cells","volume":"11","author":"Imaizumi","year":"2004","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"10.1378\/chest.11-0793_bib115","first-page":"126","article-title":"Monocrotaline induces interleukin-6 mRNA expression in rat lungs","volume":"1","author":"Bhargava","year":"1999","journal-title":"Heart Dis"},{"issue":"3","key":"10.1378\/chest.11-0793_bib116","first-page":"298","article-title":"Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy","volume":"52","author":"Langleben","year":"1985","journal-title":"Lab Invest"},{"issue":"27","key":"10.1378\/chest.11-0793_bib117","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.0610467104","article-title":"The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted","volume":"104","author":"Bonnet","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1378\/chest.11-0793_bib118","doi-asserted-by":"crossref","first-page":"H2021","DOI":"10.1152\/ajpheart.00919.2001","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats","volume":"283","author":"Ikeda","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1378\/chest.11-0793_bib119","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2006.08.109","article-title":"Mycophenolate mofetil attenuates pulmonary arterial hypertension in rats","volume":"349","author":"Suzuki","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1378\/chest.11-0793_bib120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-4800(89)90040-3","article-title":"Comparative effects of isosorbide dinitrate, prednisolone, indomethacin, and elastase on the development of monocrotaline-induced pulmonary hypertension","volume":"50","author":"Kato","year":"1989","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"10.1378\/chest.11-0793_bib121","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1378\/chest.11-0793_bib122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/096120339300200606","article-title":"Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus","volume":"2","author":"Morelli","year":"1993","journal-title":"Lupus"},{"issue":"12","key":"10.1378\/chest.11-0793_bib123","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"181","author":"Le Pavec","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.11-0793_bib124","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1253\/circj.68.227","article-title":"Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension","volume":"68","author":"Katsushi","year":"2004","journal-title":"Circ J"},{"issue":"11","key":"10.1378\/chest.11-0793_bib125","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.4049\/jimmunol.0901045","article-title":"Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP\/p300 to STAT1 in a SOCS-1-independent manner","volume":"183","author":"Strassheim","year":"2009","journal-title":"J Immunol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T19:43:08Z","timestamp":1686598988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212600348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0012369212600348"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-0793","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}